You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Prevention of thrombo-embolic disorders of venous origin in patients undergoing
orthopaedic and general surgery., Prophylaxis of venous thromboembolism in medical patients bedridden due to acute
illness., Prevention of thrombosis in extra-corporeal circulation during haemodialysis., Treatment of established deep vein thrombosis., Treatment of unstable angina and non-Q-wave myocardial infarction, administered
concurrently with aspirin., Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive
to thrombolytic treatment, including patients to be managed medically or with subsequent
Percutaneous Coronary Intervention (PCI).
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Prevention of thrombo-embolic disorders of venous origin in patients undergoing
orthopaedic and general surgery., Prophylaxis of venous thromboembolism in medical patients bedridden due to acute
illness., Prevention of thrombosis in extra-corporeal circulation during haemodialysis., Treatment of established deep vein thrombosis., Treatment of unstable angina and non-Q-wave myocardial infarction, administered
concurrently with aspirin., Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive
to thrombolytic treatment, including patients to be managed medically or with subsequent
Percutaneous Coronary Intervention (PCI).
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Prevention of thrombo-embolic disorders of venous origin in patients undergoing
orthopaedic and general surgery., Prophylaxis of venous thromboembolism in medical patients bedridden due to acute
illness., Prevention of thrombosis in extra-corporeal circulation during haemodialysis., Treatment of established deep vein thrombosis., Treatment of unstable angina and non-Q-wave myocardial infarction, administered
concurrently with aspirin., Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive
to thrombolytic treatment, including patients to be managed medically or with subsequent
Percutaneous Coronary Intervention (PCI).
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Prevention of thrombo-embolic disorders of venous origin in patients undergoing
orthopaedic and general surgery., Prophylaxis of venous thromboembolism in medical patients bedridden due to acute
illness., Prevention of thrombosis in extra-corporeal circulation during haemodialysis., Treatment of established deep vein thrombosis., Treatment of unstable angina and non-Q-wave myocardial infarction, administered
concurrently with aspirin., Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive
to thrombolytic treatment, including patients to be managed medically or with subsequent
Percutaneous Coronary Intervention (PCI).
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Prevention of thrombo-embolic disorders of venous origin in patients undergoing
orthopaedic and general surgery., Prophylaxis of venous thromboembolism in medical patients bedridden due to acute
illness., Prevention of thrombosis in extra-corporeal circulation during haemodialysis., Treatment of established deep vein thrombosis., Treatment of unstable angina and non-Q-wave myocardial infarction, administered
concurrently with aspirin., Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive
to thrombolytic treatment, including patients to be managed medically or with subsequent
Percutaneous Coronary Intervention (PCI).
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
